A detailed history of Macroview Investment Management LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Macroview Investment Management LLC holds 1,328 shares of ARDX stock, worth $6,374. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,328
Previous 1,208 9.93%
Holding current value
$6,374
Previous $8,000 12.5%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$5.28 - $7.57 $633 - $908
120 Added 9.93%
1,328 $9,000
Q2 2024

Jul 23, 2024

BUY
$5.89 - $9.31 $7,115 - $11,246
1,208 New
1,208 $8,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $742M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.